Skin conditions (dermatitis, eczema, psoriasis) decisions — 2018

The Board has remanded the issue of what initial rating is warranted for seborrheic dermatitis with rosacea since June 2, 2007 due to a lack of complete records and the need for an updated VA treatment opinion.

The Board has granted service connection for sleep apnea and pseudofolliculitis barbae, and awarded a TDIU rating based on the Veteran's service-connected disabilities.

The Veteran's appeal of the pseudofolliculitis barbae claim has been withdrawn and dismissed. The low back pain claim is remanded for further action.

The Veteran's claims for a clothing allowance for braces and medication used due to her service-connected disabilities are being remanded for additional development.

The Veteran's claims for service connection were denied previously, but new evidence has been submitted that raises a reasonable possibility of substantiating the claims. The claim for tinnitus remains denied as there is no new and material evidence. The claims for onychomycosis and fungal infection of the feet are reopened due to new evidence relating to an unestablished fact necessary to substantiate the claim, but service connection is not granted. Service connection for tinea pedis is granted.

The claim of the Veteran for service connection for a skin condition, to include as due to exposure to herbicide agents is reopened. The case is remanded for further development and an addendum opinion from a dermatologist.

The Board has decided that the Veteran's claims for service connection for an acquired psychiatric disorder and psoriasis need further examination to determine their etiology.

The Board denied service connection for acne due to burn pit exposure, finding no direct evidence linking the condition to service.

The Veteran's eczema is considered to have developed during his active service and the Board has granted service connection for this condition.

The Veteran's claim for an increased rating for his service-connected tinea pedis/unguium is remanded due to outstanding VA treatment records and the need to consider additional evidence submitted by the Veteran.

The Board has remanded the case due to insufficient evidence regarding whether the Veteran's dyshidrosis eczema is related to service.

The Board has remanded the case for further development and examination to determine if the Veteran's bilateral hearing loss is related to her service-connected eczematous dermatosis, in-service noise exposure, or any other factors.

The Board dismissed the Veteran's appeals for service connection on all issues except lumbar strain, which was granted. The remaining conditions were withdrawn by the Veteran.

The Board has remanded the case due to insufficient evidence regarding systemic therapy for tinea pedis, and a new VA examination is needed.

The Veteran's service-connected disabilities were so severe as to prevent him from engaging in substantially gainful employment since October 27, 2009. The Board has determined that the evidence of record demonstrates this and affords the benefit of doubt to grant a TDIU effective October 27, 2009.

The Board has remanded the Veteran's claims for service connection for a scalp disorder and involuntary movements, finding that additional development is needed to address the medical opinions provided.

The Veteran's appeals for bilateral chronic conjunctivitis and epilepsy have been dismissed. The Board has remanded the issues of sinus disorder, skin disorder, and acquired psychiatric disorder due to lack of evidence or need for further examination.

The Veteran's claim for a higher rating for his service-connected actinic keratosis is remanded due to inadequate examination and the need for updated medical evidence.

The Veteran's service-connected disabilities have at least as likely as not prevented her from engaging in substantially gainful employment since November 21, 2011. The Board finds TDIU is warranted as of November 21, 2011 based on the evidence currently of record.

The Veteran's claims for increased ratings for acne vulgaris and anxiety disorder, not otherwise specified, are both denied as the current evaluations of 10 percent and 30 percent respectively are appropriate given the evidence.